3-((2-Fluoro-4-iodophenyl)amino)isonicotinic acid

Catalog No. :
ACBEFP705
CAS No. :
885588-03-4
Molecular Formula :
C12H8FIN2O2
Molecular Weight :
358.11

IUPAC Name:3-((2-fluoro-4-iodophenyl)amino)isonicotinic acid

3-((2-Fluoro-4-iodophenyl)amino)isonicotinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$52.00Login to see priceIn stockInquiry
1g95%$145.00Login to see priceInquiryInquiry
5g95%$540.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-((2-Fluoro-4-iodophenyl)amino)isonicotinic acid
IUPAC Name3-((2-fluoro-4-iodophenyl)amino)isonicotinic acid
MDL No.MFCD22575002
Molecular FormulaC12H8FIN2O2
Molecular Weight358.11
SMILESO=C(O)C1=CC=NC=C1NC2=CC=C(I)C=C2F
InChI KeyLKJJUICFLVYDJQ-UHFFFAOYSA-N
Synonym3-(2-fluoro-4-iodophenylaMino)isonicotinic acid;100537;4-Pyridinecarboxylic acid, 3-[(2-fluoro-4-iodophenyl)amino]-;3-(2-Fluoro-4-iodoanilino)pyridine-4-carboxylic acid
CAS No.885588-03-4
PubChem CID59026791

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBEFP705 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSLGX216 route compound structure diagram
    ACSLGX21629632-74-4 In Stock
  2. Plus
  3. ACDKWS138 route compound structure diagram
    ACDKWS138393-53-3 In Stock
  4. Then
  5. ACBEFP705 route product structure diagram
    ACBEFP705885588-03-4 In Stock
Inquiry

2. ACBEFP705 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSLGX216 route compound structure diagram
    ACSLGX21629632-74-4 In Stock
  2. Plus
  3. ACILJM817 route compound structure diagram
    ACILJM81788912-27-0 In Stock
  4. Then
  5. ACBEFP705 route product structure diagram
    ACBEFP705885588-03-4 In Stock
Inquiry

Comments (0)